Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares Outstanding
Ratios

LifeStance Health (LFST) Depreciation & Amortization (IS) (2020 - 2025)

Historic Depreciation & Amortization (IS) for LifeStance Health (LFST) over the last 6 years, with Q3 2025 value amounting to $13.6 million.

  • LifeStance Health's Depreciation & Amortization (IS) fell 1030.76% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $56.0 million, marking a year-over-year decrease of 2867.15%. This contributed to the annual value of $71.0 million for FY2024, which is 1179.43% down from last year.
  • According to the latest figures from Q3 2025, LifeStance Health's Depreciation & Amortization (IS) is $13.6 million, which was down 1030.76% from $14.0 million recorded in Q2 2025.
  • In the past 5 years, LifeStance Health's Depreciation & Amortization (IS) registered a high of $22.6 million during Q1 2024, and its lowest value of $12.2 million during Q1 2021.
  • For the 5-year period, LifeStance Health's Depreciation & Amortization (IS) averaged around $16.6 million, with its median value being $15.7 million (2022).
  • In the last 5 years, LifeStance Health's Depreciation & Amortization (IS) surged by 13516.2% in 2021 and then tumbled by 3903.56% in 2025.
  • Over the past 5 years, LifeStance Health's Depreciation & Amortization (IS) (Quarter) stood at $15.4 million in 2021, then grew by 22.99% to $18.9 million in 2022, then grew by 17.63% to $22.2 million in 2023, then plummeted by 33.96% to $14.7 million in 2024, then dropped by 7.59% to $13.6 million in 2025.
  • Its Depreciation & Amortization (IS) stands at $13.6 million for Q3 2025, versus $14.0 million for Q2 2025 and $13.8 million for Q1 2025.